Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 9.27812 | 97 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.23162 | 94 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 9.50816 | 97 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.94563 | 93 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.0137 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.87609 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.78441 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.98991 | 96 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.8514 | 96 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 9.18605 | 97 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.12614 | 90 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.61605 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.35543 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.03967 | 94 |